Guanine nucleotides couple receptors to stimulate or inhibit adenylate cyclase as well as regulate binding of neurotransmitters.
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To explore the relationship between these different functions of guanosine 5'-triphosphate (GTP), rat brain membranes were preincubated in 50 mM sodium acetate, pH 4.5, which increased GTP regulation of 3H-opiate agonist binding. Assay of adenylate cyclase in the low pH-pretreated membranes revealed no loss of basal activity but a dramatic loss in fluoride-and guanylyl-5'-imidodiphosphate-stimulated activity, thus suggesting a loss in stimulatory guanine nucleotide coupling function. Manganese stimulation, which presumably occurs on the catalytic subunit of adenylate cyclase directly, was not affected by low pH treatment.
In striatum, dopamine-stimulated adenylate cyclase was eliminated, but inhibition of adenylate cyclase by D-Ala*-Met5-enkephalinamide (D-Ala enk) was increased by low pH treatment. The effect of low pH on sodium fluoride-stimulated and D-Ala enk-inhibited adenylate cyclase could be reversed by addition of either cis-vaccenic acid or phosphatidylcholine to treated membranes, but the effect on GTP regulation of binding was not reversed by lipid incorporation.
These results suggest that fundamental differences exist between membrane components which couple receptors to adenylate cyclase and those that regulate neurotransmitter binding.
Guanine nucleotides perform dual roles in neurotransmitter function
by coupling receptors to adenylate cyclase and by regulating binding of neurotransmitters to receptors (Rodbell, 1980) . Moreover, in recent years it has become clear that neurotransmitters can affect adenylate cyclase in two ways: either to stimulate or to inhibit formation of CAMP. These two latter classes of GTP function may be mediated by separate guanine nucleotide-binding proteins: N, for stimulatory receptors and Ni for inhibitory receptors (Rodbell, 1980) . Although N, has been well characterized in several systems as a GTPbinding protein and a GTPase (Cassel and Selinger, 1978) , less information is known about Ni. Several recent studies (Jakobs and Schultz, 1983; Jakobs et al., 1983) have provided evidence that N, and Ni represent different proteins which can at least be,differentiated by labeling with different toxins: cholera toxin for N, (Cassel and Pfeuffer, 1978) and pertussis toxin for Ni (Katada and Ui, 1982) . However, the precise relationship between these two proposed proteins is not clear, nor is the mechanism by which these subunits interact with various receptors to regulate binding understood in any detail.
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Several kinds of membrane treatments can alter the coupling of adenylate cyclase with neurotransmitter receptors through N,. For example, N, activity in brain membranes can be inactivated by heat or can be removed from membrane sites by incubation with colchicine (Rasenick et al., 1981) . In erythrocytes, coupling efficiency of N, can be increased by addition of fatty acids to decrease membrane microviscosity (Hanski et al., 1979) , while in brain, N,-stimulated adenylate cyclase can be increased by phospholipase AZ (Reese and Hoss, 1983) . The finding that treatment of brain membranes at pH 4.5 increased guanine nucleotide regulation of 3H-opiate agonist binding (Lambert and Childers, 1984) has provided an interesting opportunity to explore the relationships between different functions of GTP. The function of N, in these membranes can be studied by assay of adenylate cyclase in the presence of sodium fluoride or guanylyl-5'-imidodiphosphate (Gpp(NH)p, the nonhydrolyzable analogue of GTP), agents which stimulate the enzyme by interacting directly at N, (Ross et al., 1978; Rasenick and Bitensky, 1980) . The function of Ni can be studied by assaying adenylate cyclase in the presence of opiate agonists which have been shown to inhibit the enzyme with GTP-dependent reactions in brain membranes (Collier and Roy, 1974; Law et al., 1981; Cooper et al., 1982) and in neuroblastoma x glioma hybrid cells (Klee and Niremberg, 1976; Goldstein et al., 1977; Blume et al., 1979; Law et al., 1982; McGee and Kenimer, 1982) . The present study explores the action of these agents on adenylate cyclase activity in both normal and low pH-pretreated rat brain membranes. 
Results
Effect of low pH treatment on stimulation of adenylate cyclase by N,. As demonstrated in the previous paper in this series (Lambert and Childers, 1984) , treatment of brain membranes at pH 4.5 increased regulation of opiate receptor binding by guanine nucleotides.
To explore the effect of this low pH treatment on other guanine nucleotide functions associated with neurotransmitter receptors, adenylate cyclase was assayed in the presence and absence of sodium fluoride and Gpp(NH)p, which stimulate adenylate cyclase directly through the N, subunit. In preliminary studies, pretreatment of brain membranes at pH 4.5 caused appreciable loss (greater than 40%) in basal adenylate cyclase activity. Later experiments prevented the loss of basal activity by incubation at pH 4.5 on ice instead of at room temperature, and by including magnesium and dithiothreitol in the pH 4.5 buffer. This buffer continued to produce the same increase in guanine nucleotide regulation of opiate agonist binding as the previous low pH treatment (data not shown). Figure   1 shows the results of pH 4.5 preincubation on adenylate cyclase activity in whole brain membranes.
In control (treated at pH 7.4) preparations, sodium fluorideand Gpp(NH)p-stimulated activity increased to 195% and 250% of basal levels, respectively, while manganese, which bypasses the Vol. 4, No. 11, Nov. 1984 N, subunit and stimulates the catalytic unit of adenylate cyclase directly (Limbird et al., 1978) , increased activity to 350% of basal levels. In pH 4.5treated membranes, basal activity was not significantly changed compared to control membranes. However, much of sodium fluoride-and Gpp(NH)p-stimulated adenylate cyclase was lost, with increases to only 105% and 140%, respectively.
On the other hand, manganese stimulation was largely unchanged compared to control preparations, with an increase to 340% of basal activity. When adenylate cyclase was assayed in the presence of both Gpp(NH)p and manganese, the increase was to 290%, a level which was even less than manganese-stimulated activity alone. These results suggest that the low pH treatment caused a selective loss in N,-stimulated adenylate cyclase, with no significant loss in catalytic unit activity.
The time course for the low pH effect on Gpp(NH)p-stimulated adenylate cyclase was rapid (Fig. 2) . Although no significant loss of stimulated activity could be seen after 2 min of preincubation at pH 4.5, full loss of activity was seen after 5 min, with no further loss in activity up to 30 min of preincubation. Beginning at 30 min, significant loss of basal activity (greater than 20%) began to be observed (data not shown); therefore, most experiments utilized a IO-min incubation time for determination of low pH effects. Effect of 1owpH treatment on adenylate cyclase in rat striatum. Although whole brain membranes were useful in determining effects on agents that stimulate N, directly (such as sodium fluoride and Gpp(NH)p), specific brain regions must be utilized to study effects of low pH treatment on specific neurotransmitter receptor-coupled adenylate cyclase. Therefore, membranes were prepared from rat striatum to determine activity of dopamine-stimulated and opiate-inhibited adenylate cyclase. Results (Fig. 3) demonstrated that, as in whole brain membranes, the low pH pretreatment did not reduce basal adenylate cyclase activity. In control striatal membranes, sodium fluoride stimulated activity to 220% of basal levels, while dopamine increased activity to 140%. In our hands, opiate agonists had very little effect on basal adenylate cyclase activity in untreated crude membranes from striatum; an inhibition to 90% of basal levels was a typical finding. In low pH-pretreated membranes, as in whole brain, sodium fluoride-stimulated activity was decreased to 105%; Gpp(NH)p-stimulated activity was similarly decreased (not shown). In addition, dopamine-stimulated adenylate cyclase was completely eliminated in low pH-pre- 10 pM D-Ala enk inhibited activity to 60% of basal levels. Thus, as the function of N, was attenuated by treatment at low pH, the function of Ni appeared to be increased.
A dose response curve for D-Ala enk inhibition of adenylate cyclase in low pH-pretreated striatal membranes is seen in Figure 4 . These results demonstrate that D-Ala enk produced a maximum inhibition to 60% of basal activity, with an EDs0 of approximately 0.2 pM. This affinity is similar to those previously observed for opiate inhibition of adenylate cyclase in brain membranes (Law et al., 1981) and neuroblastoma x glioma cells (Blume et al., 1979) . The dose response curve for D-Ala enk was shifted to the right in the presence of 0.2 pM naloxone, which completely antagonized enzyme inhibition up to 1 pM D-Ala enk. Therefore, the inhibition caused by D-Ala enk appears to be genuinely mediated through opiate receptors.
Reversal of low pH effects on adenylate cyclase with lipid incorporation.
Several possible mechanisms could be responsible for the apparent loss of N, function in brain membranes after pretreatment at pH 4.5. One explanation could be that low pH removes some fraction of N, proteins from membrane sites. However, preliminary attempts to reconstitute membranes with supernatants from low pH incubations failed to restore any significant stimulation of adenylate cyclase by sodium fluoride or Gpp(NH)p (data not shown). Another possibility is that low pH could be denaturing membrane components and altering membrane fluidity to decrease coupling of N, with adenylate cyclase. Experiments with /3-adrenergic receptors in erythrocytes have shown that coupling of receptors with adenylate cyclase depends on membrane fluidity and that membrane-fluidizing agents such as cis-vaccenic acid can increase coupling (Hanski et al., 1979) . To explore this possibility, whole brain membranes pretreated at pH 4.5 were incubated with different concentrations of cis-vaccenic acid and then assayed for sodium fluoride-stimulated adenylate cyclase activity. Results (Fig. 5) showed that addition of 1 pmol of cisvaccenic acid/mg of protein to low pH-pretreated membranes Membranes were pretreated at pH 4.5 as described in the legendto Figure  1 (Fig. 6 ). As seen earlier (Fig. 5) , cisvaccenic acid had no effect on sodium fluoride-stimulated activity in control membranes, but in low pH-pretreated membranes, cis-vaccenic acid restored sodium fluoride-stimulated adenylate cyclase nearly to control levels (Fig. 6A) . In contrast, addition of cis-vaccenic acid had no significant effect on opiate receptor binding (Fig. 6B) . The effect of 10 pM Gpp(NH)p was increased from 36% to 60% inhibition of [3H]-D-Ala enk binding by low pH pretreatment; the Gpp(NH)p effect remained at 60% inhibition after incorporation of cis-vaccenic acid into low pH-treated membranes. cis-Vaccenic acid had no effect on binding itself or on Gpp(NH)p inhibition of binding in control membranes (Fig. 6B) . It is important to note that cyclase and binding assays were accomplished in the same membranes; thus, low pH-pretreated membranes which had their N, function restored by lipid incorporation still exhibited an increase in GTP regulation of agonist binding.
The next question was whether lipid incorporation could reverse the increased opiate inhibition of adenylate cyclase caused by low pH pretreatment. Studies on whole brain revealed that, in addition to cis-vaccenic acid, phosphatidylcholine also restored sodium fluoride-stimulated adenylate cyclase activity in pH 4.5-pretreated membranes (not shown). Therefore, adenylate cyclase was assayed in low pH-pretreated striatal membranes in the presence and absence of phosphatidylcholine.
Results (Fig.  7) showed that, as before, inhibition of adenylate cyclase by D-Ala enk was minimal in control membranes and was significant (52% of basal levels) in pH 4.5 pretreated membranes. Sodium fluoride-stimulated activity again was lost after low pH pretreatment. In low pH-pretreated membranes incubated with 1 pmol of phosphatidylcholine/mg of protein, sodium fluoride-stimulated activity was restored to 80% of control levels, whereas D-Ala enk-inhibited activity was ization studies (data not shown). The finding that low pH decreased to 40% of the inhibition seen in pH 4.5pretreated effects were not directly associated with membrane fluidity was membranes without phosphatidylcholine. When several consupported by the result (not shown) that truns-vaccenic acid, centrations of phosphatidylcholine were used to confirm these which does not increase membrane fluidity ( of the proteins themselves, since the loss of sodium fluoridestimulated activity could be effectively reversed by addition of lipids to membranes.
The various functions of guanine nucleotides in neurotransmitter receptor actions are summarized in 
